Items where Author is "Flühmann, Beat"

2021

Sofia, Natalia and Mühlebach, Stefan and Musazzi, Umberto M. and Khatib, Rani and Martinez Sesmero, José Manuel and Lipp, Hans-Peter and Surugue, Jacqueline and Di Francesco, Tiziana and Flühmann, Beat. (2021) How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries. Pharmaceutics, 13 (7). p. 1010.

Hertig, John B. and Shah, Vinod P. and Flühmann, Beat and Mühlebach, Stefan and Stemer, Gunar and Surugue, Jacqueline and Moss, Rob and Di Francesco, Tiziana. (2021) Tackling the challenges of nanomedicines: are we ready? American Journal of Health-System Pharmacy : AJHP, 78 (12). pp. 1047-1056.

2019

Flühmann, Beat and Ntai, Ioanna and Borchard, Gerrit and Simoens, Steven and Mühlebach, Stefan. (2019) Nanomedicines: The magic bullets reaching their target? European journal of pharmaceutical sciences, 128. pp. 73-80.

2018

Knoeff, Josefien and Flühmann, Beat and Mühlebach, Stefan. (2018) Medication practice in hospitals: are nanosimilars evaluated and substituted correctly? European journal of hospital pharmacy : science and practice, 25 (2). pp. 79-84.

2017

Hussaarts, Leonie and Mühlebach, Stefan and Shah, Vinod P. and McNeil, Scott and Borchard, Gerrit and Flühmann, Beat and Weinstein, Vera and Neervannan, Sesha and Griffiths, Elwyn and Jiang, Wenlei and Wolff-Holz, Elena and Crommelin, Daan J. A. and de Vlieger, Jon S. B.. (2017) Equivalence of complex drug products: advances in and challenges for current regulatory frameworks. Annals of the New York Academy of Sciences, 1407 (1). pp. 39-49.

Astier, Alain and Barton Pai, Amy and Bissig, Marco and Crommelin, Daan J. A. and Flühmann, Beat and Hecq, Jean-Daniel and Knoeff, Josefien and Lipp, Hans-Peter and Morell-Baladrón, Alberto and Mühlebach, Stefan. (2017) How to select a nanosimilar. Annals of the New York Academy of Sciences, 1407 (1). pp. 50-62.

2016

de Vlieger , Jon S. B. and Borchard, Gerrit and Shah, Vinod P. and Flühmann, Beat and Neervannan, Sesha and Mühlebach , Stefan F.. (2016) Is the EU ready for non-biological complex drug products? Generics and biosimilars initiative journal, 5 (3). pp. 101-102.

2015

Mühlebach , Stefan F. and Shah, Vinod P. and McNeil, Scott E. and Borchard, Gerrit and Weinstein, Vera and de Vlieger , Jon S. B. and Flühmann, Beat and Crommelin, Daan J. A. and Neervannan, Sesha. (2015) NBCDS and their follow-on versions: time for an editorial section (perspective). Generics and Biosimilars Initiative Journal, 4 (4). pp. 167-170.

Crommelin, Daan J. A. and Shah, Vinod P. and Klebovich, Imre and McNeil, Scott E. and Weinstein, Vera and Flühmann, Beat and Mühlebach, Stefan and de Vlieger, Jon S. B.. (2015) The similarity question for biologicals and non-biological complex drugs. European journal of pharmaceutical sciences, 76. pp. 10-17.

2014

Schellekens, Huub and Stegemann, Sven and Weinstein, Vera and de Vlieger, Jon S. B. and Flühmann, Beat and Mühlebach, Stefan and Gaspar, Rogério and Shah, Vinod P. and Crommelin, Daan J. A.. (2014) How to regulate nonbiological complex drugs (NBCD) and their follow-on versions: points to consider. The AAPS journal, 16 (1). pp. 15-21.

2012

Borchard, Gerrit and Flühmann, Beat and Mühlebach, Stefan. (2012) Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies. Regulatory toxicology and pharmacology, 64 (2). pp. 324-328.